Related Experiment Video
Updated: Jul 6, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Intravitreal injection of bevacizumab in Eales disease
Cem Küçükerdönmez1, Yonca A Akova, Gürsel Yilmaz
1Department of Ophthalmology, Baskent University Faculty of Medicine, Ankara, Turkey. drcemk@hotmail.com
Purpose:
To report a case of presumed Eales disease that showed regression of retinal neovascularization after the use of intravitreal bevacizumab.
Design:
Retrospective, interventional case report.
Methods:
Broad retinal neovascularization in a patient with presumed Eales disease did not regressed despite adequate photocoagulation treatment, and bevacizumab (1.25 mg) was injected intravitreally. The patient was followed up for 1 year.
Results:
One week after injection, fluorescein angiography demonstrated dramatic regression of retinal neovascularization. After 12-months, visual acuity was improved and no signs of recurrence were observed.
Conclusion:
Intravitreal bevacizumab may be effective as an adjunctive treatment of retinal neovascularization in patients with Eales disease.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
